Antimicrobial Efficacy of Nano-Based ICM on E.F
Antimicrobial Efficacy of Nano-Based Intracanal Medications on Enterococcus Faecalis
Tanta University
30 participants
Jan 2, 2024
INTERVENTIONAL
Conditions
Summary
This in-vivo study aims to evaluate the antimicrobial effect of nano based intracanal medications (Triple antibiotic-loaded chitosan nanoparticles and chlorohexidine loaded by silver nanoparticles) on Enterococcus faecalis count reduction in secondary endodontic infection cases.
Eligibility
Inclusion Criteria6
- Single rooted, single canal premolar teeth.
- Teeth indicated for non-surgical root canal retreatment.
- Teeth have signs and/or symptoms of post-treatment disease manifested by recurrent acute and/or chronic periapical abscess.
- Teeth have clinical signs and symptoms of endodontic failure as sensitivity to percussion, pain, swelling or fistula.
- Teeth with radiographic features of endodontic failure as persistent periapical lesion or widening of periodontal ligament.
- Symptomatic or asymptomatic teeth with short root canal filling indicated for prosthetic restoration
Exclusion Criteria8
- Patients with any systemic diseases.
- Pregnant or lactating patients.
- Immunocompromised patients.
- Non-restorable tooth.
- Calcified root canal.
- Teeth with root fracture.
- Teeth with periodontal pocket deeper than 4mm.
- Teeth have procedural error like ledge, broken instrument, or perforation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The paper points of three samples (S1, S2, and S3) will be placed each in a sterile falcon tube containing 1ml of brain heart infusion and labeled according to the type of intracanal medication used. Samples will be homogenized by the vortex and and one micron of each sample will be cultured on Bile Esculin Agar for E. faecalis. The plate will be labeled as the tube of the same sample and incubated at 37οC for 24-48 h and then after incubation, the total numbers of E.faecalis will be counted and calculated to get the colony forming units (CFU/ml).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06533215